Good news in the field of malaria treatment in South Africa. Garsun® (Equity Pharmaceuticals) is now registered in South Africa. Garsun® contains artesunate 60 mg per vial. Garsun® is indicated for the treatment of severe malaria caused by Plasmodium falciparum, in both adults and children.